Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Insulet Corporation (PODD : NSDQ)

• Company Description    Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. Number of Employees: 3,900

• Price / Volume Information    Yesterday's Closing Price: $284.24 Daily Weekly Monthly 20 Day Moving Average: 573,828 shares Shares Outstanding: 70.35 (millions) Market Capitalization: $19,995.40 (millions) Beta: 1.40 52 Week High: $354.88 52 Week Low: $230.05 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.03% -9.88% 12 Week -11.28% -12.71% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 100 NAGOG PARK - ACTON,MA 01720 USA ph: 978-600-7000 fax: 978-600-0120 ctrachtman@insulet.com http://www.insulet.com

• General Corporate Information    Officers James R. Hollingshead - Chief Executive Officer Ana M. Chadwick - Chief Financial Officer; Executive Vice President Luciana Borio - Director Wayne A.I. Frederick - Director Jessica Hopfield - Director Peer Information Insulet Corporation (BJCT) Insulet Corporation (CADMQ) Insulet Corporation (APNO) Insulet Corporation (UPDC) Insulet Corporation (IMTIQ) Insulet Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 45784P101 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/19/26 Share - Related Items Shares Outstanding: 70.35 Most Recent Split Date: (:1) Beta: 1.40 Market Capitalization: $19,995.40 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $1.20 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $6.18 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 11.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 29.02% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/19/26

• Fundamental Ratios P/E Current FY Estimate: 46.00 Trailing 12 Months: 62.06 PEG Ratio: 1.58 Price Ratios Price/Book: 14.45 Price/Cash Flow: 64.07 Price / Sales: 7.93 EPS Growth vs. Year Ago Period: 37.78% vs. Previous Quarter: 5.98% Sales Growth vs. Year Ago Period: 29.86% vs. Previous Quarter: 8.81% ROE 12/31/25 - - 09/30/25 - 24.36 06/30/25 - 23.78 ROA 12/31/25 - - 09/30/25 - 10.02 06/30/25 - 9.30 Current Ratio 12/31/25 - - 09/30/25 - 2.87 06/30/25 - 2.26 Quick Ratio 12/31/25 - - 09/30/25 - 2.18 06/30/25 - 1.81 Operating Margin 12/31/25 - - 09/30/25 - 13.01 06/30/25 - 12.91 Net Margin 12/31/25 - - 09/30/25 - 9.76 06/30/25 - 10.01 Pre-Tax Margin 12/31/25 - - 09/30/25 - 12.32 06/30/25 - 11.47 Book Value 12/31/25 - - 09/30/25 - 19.67 06/30/25 - 20.79 Inventory Turnover 12/31/25 - - 09/30/25 - 1.63 06/30/25 - 1.57 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.68 06/30/25 - 0.64 Debt-to-Capital 12/31/25 - - 09/30/25 - 40.31 06/30/25 - 39.09

Powered by Zacks Investment Research ©